Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the full record of transactions filed by Starr Kevin P, Director. Insider active across 1 company, notably Sage Therapeutics, Inc.. In total, 1 disclosures have been logged. Split: 1 buy · 0 sell. Total volume traded: €834k. History available since 16 June 2021. The latest transaction was filed on 16 June 2021 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration
Kevin P. Starr is a Board Member at Sage Therapeutics, Inc. He plays a key role in the strategic direction of the company, ensuring it adheres to best practices in governance. His experience in the healthcare sector is an asset for innovation initiatives.